Large Group Aggregate Rates and Prescription Drug Cost Transparency

The Department of Managed Health Care conducts an annual public meeting regarding large group aggregate rates as required by Senate Bill 546 (Leno, Chapter 801, Statutes of 2015) and on prescription drug costs transparency pursuant to Senate Bill 17 (Hernandez, Chapter 603, Statutes of 2017). The meeting provides an opportunity for a public discussion regarding the reasons for changes in the rates, benefits, and cost sharing in the large group market as well as prescription drug costs in the commercial market.

Previous meeting agendas, minutes and presentations:

March 5, 2020
Agenda

Presentations:

• Public Meeting on Large Group Aggregate Rates and Prescription Drug Costs

Reports:

• Large Group Aggregate Rates and Prescription Drug Costs

March 12, 2019
Agenda 

February 7, 2018
Agenda 

Presentations:

• Public Meeting on Large Group Aggregate Rates

February 1, 2017
Agenda

Presentations:

• Public Meeting on Large Group Aggregate Rates